Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)

被引：0
|
作者：
Emilie Thivat
Mélanie Casile
Juliette Moreau
Ioana Molnar
Sandrine Dufort
Khalide Seddik
Géraldine Le Duc
Olivier De Beaumont
Markus Loeffler
Xavier Durando
Julian Biau
机构：
[1] Centre Jean Perrin,Department of Clinical Research, Délégation Recherche Clinique Et Innovation
[2] INSERM U1240 IMoST,Department of Radiation Oncology
[3] Université Clermont Auvergne,Oncology Department
[4] UMR 501,undefined
[5] Centre d’Investigation Clinique,undefined
[6] Centre Jean Perrin,undefined
[7] NH TherAguix SA,undefined
[8] Centre Jean Perrin,undefined
来源：
BMC Cancer | / 23卷
关键词：
Glioblastoma; Nanoparticles; AGuIX; Nanomedicine; Radiotherapy; Radiosensitization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] NCCTG phase I trial of temsirolimus (CCI-779) and temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients
    Sarkaria, J. N.
    Galanis, E.
    Wu, W.
    Giannini, C.
    Jaeckle, K. A.
    Doyle, L.
    Uhm, J.
    Brown, P.
    Dietz, A. B.
    Buckner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
    Stupp, Roger
    Hegi, Monika E.
    Neyns, Bart
    Goldbrunner, Roland
    Schlegel, Uwe
    Clement, Paul M. J.
    Grabenbauer, Gerhard G.
    Ochsenbein, Adrian F.
    Simon, Matthias
    Dietrich, Pierre-Yves
    Pietsch, Torsten
    Hicking, Christine
    Tonn, Joerg-Christian
    Diserens, Annie-Claire
    Pica, Alessia
    Hermisson, Mirjam
    Krueger, Stefan
    Picard, Martin
    Weller, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2712 - 2718
  • [23] Phase I/II study to evaluate the safety and clinical efficacy of atezolizumab (atezo; aPDL1) in combination with temozolomide (TMZ) and radiation in patients with newly diagnosed glioblastoma (GBM).
    Weathers, Shiao-Pei S.
    Kamiya-Matsuoka, Carlos
    Harrison, Rebecca A.
    Liu, Diane D.
    Dervin, Shannon
    Yun, Cindy
    Loghin, Monica Elena
    Penas-Prado, Marta
    Majd, Nazanin
    Yung, W. K. Alfred
    O'Brien, Barbara Jane
    De Groot, John Frederick
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Phase I trial of vatalanib (PTK787) in combination with standard radiation and temozolomide in patients with newly diagnosed glioblastoma
    Batchelor, T.
    Eichler, A. F.
    Plotkin, S. R.
    Drappatz, J.
    Wen, P.
    Sorensen, A. G.
    Gerstner, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [25] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, Sied
    Pierscianek, Daniela
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca-Ligia
    Krex, Dietmar
    Sure, Ulrich
    Scheffler, Bjoern
    Stuschke, Martin
    Glas, Martin
    NEURO-ONCOLOGY, 2021, 23 : 68 - 68
  • [26] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, S.
    Pierscianek, D.
    Proescholdt, M.
    Hau, P.
    Grosu, A.
    Krex, D.
    Sure, U.
    Scheffler, B.
    Stuschke, M.
    Glas, M.
    NEURO-ONCOLOGY, 2021, 23 : 50 - 50
  • [27] A RANDOMIZED, PHASE I/II TRIAL OF IXAZOMIB IN COMBINATION WITH STANDARD THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MGMT METHYLATED GLIOBLASTOMA (GBM) STUDY DESIGN
    Kong, Xiao-Tang
    Lai, Albert
    Carrillo, Jose A.
    Fu, Dan Beverly
    Meyskens, Frank
    Bota, Daniela A.
    NEURO-ONCOLOGY, 2018, 20 : 13 - 13
  • [28] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
    Kebir, Sied
    Lazaridis, Lazaros
    Schmidt, Teresa
    Oster, Christoph
    Pierscianek, Daniela
    Guberina, Nika
    Kleinschnitz, Christoph
    Proescholdt, Martin
    Hau, Peter
    Grosu, Anca-Ligia
    Sure, Ulrich
    Scheffler, Bjoern
    Stuschke, Martin
    Glas, Martin
    NEURO-ONCOLOGY, 2020, 22 : 61 - 61
  • [29] A PHASE II STUDY OF TUMOR TREATING FIELDS IN COMBINATION WITH BEVACIZUMAB AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED, UNRESECTABLE GLIOBLASTOMA
    Sumrall, Ashley
    Haggstrom, Daniel
    Burri, Stuart
    Symanowski, James
    NEURO-ONCOLOGY, 2017, 19 : 16 - 16
  • [30] PriCoTTF Trial: A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma
    Kebir, S.
    Lazaridis, L.
    Schmidt, T.
    Oster, C.
    Pierscianek, D.
    Guberina, N.
    Kleinschnitz, C.
    Proescholdt, M.
    Hau, P.
    Grosu, A. -L
    Sure, U.
    Scheffler, B.
    Stuschke, M.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S74 - S74
12345